ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1930

Blue Digit Syndrome as the Initial Presentation of Various Diseases: A Case Series

Raquel Ugena García1, Juan José Lluch Galcerá2, Cristina Calomarde Gomez1, Ivette Casafont-Sole3 and Lourdes Mateo Soria2, 1Rheumatology department. Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 2Hospital Germans Trias i Pujol, Badalona, Spain, 3Hospital Universitari Germans Trias i Pujol, Badalona, Spain

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, Cutaneous, Raynaud's, Systemic sclerosis, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1913–1944) Miscellaneous Rheumatic & Inflammatory Diseases Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Blue Digit Syndrome (BDS) represents the cutaneous manifestation of numerous diseases that cause blue discoloration in one or more fingers in the absence of trauma and with preserved pulses. The diagnosis of the underlying cause is crucial to preserve the affected extremity and treat the underlying disease. While it may not be the most common etiology, many systemic autoimmune and inflammatory diseases can present with cutaneous manifestations such as BDS. These conditions may include connective tissue diseases like systemic sclerosis (SSc), vasculitis, and other rheumatic disorders. Being sometimes the only exploratory finding, diagnosis may be challenging.

This study aimed to define the prevalence of different etiologies in patients with BDS. Additionally, the clinical characteristics, assessment findings, complementary investigations, and patient outcomes were described.

Methods: Ambispective cohort study. All patients admitted to the Rheumatology Department of Hospital Universitari Germans Trias i Pujol for blue digit syndrome between January 2017 and December 2022 were included.

Results: Forty-five patients (20 males and 25 females) were included with a mean age of 56.4 years. 46.7% were smokers. 48.9% had cardiovascular risk factors. The most frequent diagnoses were thromboangiitis obliterans (TAO) (22.2%) systemic sclerosis (SSc) (15.6%), severe atherosclerosis (8.9%), haematological disorder (8.9%) and cryoglobulinemia (8.9%). 10% of cases were considered idiopathic, and 12.5% were multifactorial. To be noted, a patient initially diagnosed of idiopathic blue finger syndrome was ultimately diagnosed with prostate cancer. Half of the cases presented with involvement limited to the upper extremities. 28.9% of patients had systemic symptoms. Examinations included autoimmunity tests, echocardiogram, arteriography, blood analysis among others. Skin biopsies were performed in 13 out of 40 patients, of which 2 out of 13 showed diagnostic findings of cholesterol emboli, 1 out of 13 showed calciphylaxis, 1 out of 13 showed vasculitis, and the remaining cases (9 out of 13) had no specific findings. 56% of the cases resolved with medical treatment. 8 patients (17.8) of patients required surgical amputation of the affected finger.

Conclusion: In our experience, the most common cause of BDS was TAO, followed by SSc. The differential diagnosis is broad and requires multiple complementary investigations, although some may have limited utility and carry the risk of iatrogenic harm. Therefore, a reasoned and systematic diagnostic approach based on initial suspicion is crucial.


Disclosures: R. Ugena García: None; J. Lluch Galcerá: None; C. Calomarde Gomez: None; I. Casafont-Sole: None; L. Mateo Soria: None.

To cite this abstract in AMA style:

Ugena García R, Lluch Galcerá J, Calomarde Gomez C, Casafont-Sole I, Mateo Soria L. Blue Digit Syndrome as the Initial Presentation of Various Diseases: A Case Series [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/blue-digit-syndrome-as-the-initial-presentation-of-various-diseases-a-case-series/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/blue-digit-syndrome-as-the-initial-presentation-of-various-diseases-a-case-series/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology